← Back to Treatments
🏅 FDA Orphan Designation

Extraneal (with 7.5% Icodextrin) Peritoneal Dialysis Solutio

Icodextrin 7.5% with Electrolytes Peritoneal Dialysis Solution

Manufacturer: Baxter Healthcare Corporation

Indicated for:
Off-periods in Parkinson disease not responding to oral treatmentOrphanChronic intestinal failure

FDA-Approved Indications (2)

For use as a single daily exchange for the long (8-16 hour) dwell during continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) for the management of chronic renal fai…

For use as a single daily exchange for the long (8-16 hour) dwell during continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) for the management of chronic renal fai…

Population: all ages

Indications & Usage

For use as a single daily exchange for the long (8-16 hour) dwell during continuous ambulatory peritoneal dialysis (CAPD) or automated peritoneal dialysis (APD) for the management of chronic renal failure.

Medical disclaimer: This information is for educational purposes only. Always consult a qualified healthcare provider before making treatment decisions. Data sourced from FDA and current as of our last update.